000 | 01993 a2200577 4500 | ||
---|---|---|---|
005 | 20250517192909.0 | ||
264 | 0 | _c20180525 | |
008 | 201805s 0 0 eng d | ||
022 | _a1939-327X | ||
024 | 7 |
_a10.2337/db17-0595 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRichards, Paul | |
245 | 0 | 0 |
_aMondoA Is an Essential Glucose-Responsive Transcription Factor in Human Pancreatic β-Cells. _h[electronic resource] |
260 |
_bDiabetes _c03 2018 |
||
300 |
_a461-472 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aActive Transport, Cell Nucleus _xdrug effects |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBasic Helix-Loop-Helix Leucine Zipper Transcription Factors _xantagonists & inhibitors |
650 | 0 | 4 |
_aCarrier Proteins _xgenetics |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aCyclic AMP _xmetabolism |
650 | 0 | 4 | _aExenatide |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 |
_aGlucose _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIncretins _xpharmacology |
650 | 0 | 4 |
_aInsulin _xmetabolism |
650 | 0 | 4 | _aInsulin Secretion |
650 | 0 | 4 |
_aInsulin-Secreting Cells _xdrug effects |
650 | 0 | 4 |
_aIntracellular Signaling Peptides and Proteins _xgenetics |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPeptides _xpharmacology |
650 | 0 | 4 | _aRNA Interference |
650 | 0 | 4 |
_aSecond Messenger Systems _xdrug effects |
650 | 0 | 4 |
_aThioredoxins _xgenetics |
650 | 0 | 4 | _aTissue Culture Techniques |
650 | 0 | 4 |
_aVenoms _xpharmacology |
700 | 1 | _aRachdi, Latif | |
700 | 1 | _aOshima, Masaya | |
700 | 1 | _aMarchetti, Piero | |
700 | 1 | _aBugliani, Marco | |
700 | 1 | _aArmanet, Mathieu | |
700 | 1 | _aPostic, Catherine | |
700 | 1 | _aGuilmeau, Sandra | |
700 | 1 | _aScharfmann, Raphael | |
773 | 0 |
_tDiabetes _gvol. 67 _gno. 3 _gp. 461-472 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2337/db17-0595 _zAvailable from publisher's website |
999 |
_c27929432 _d27929432 |